Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Pancreatic Cancer

 

Temozolomide and Pazopanib Hydrochloride for Pancreatic Cancer
A Phase I/II Study of the Combination of Temozolomide and Pazopanib in Advanced Pancreatic Neuroendocrine Tumors (PNET)

Investigator: Gabriela Chiorean, MD;   Conditions: Pancreatic Cancer;    Status: Recruiting;   Study ID: NCT01465659